Understanding the epidemiology and perceived efficacy of cannabis use in patients with chronic musculoskeletal pain.
Timothy LerouxPrabjit AjrawatKala SundararajanNaomi Maldonado-RodriguezBheeshma RaviRajiv GandhiRaja RampersaudChristian VeilletteNizar MahomedHance ClarkePublished in: Journal of cannabis research (2024)
One in five patients presenting to an orthopaedic surgeon with chronic MSK pain are using or have used cannabis with the specific intent to manage their pain, and most report it to be effective. Among non-users, two-thirds reported an interest in using cannabis to manage their MSK pain, but common barriers to use existed. Future double-blind placebo-controlled trials are required to understand if this reported efficacy is accurate, and what role, if any, cannabis may play in the management of chronic MSK pain.
Keyphrases
- chronic pain
- pain management
- neuropathic pain
- placebo controlled
- double blind
- end stage renal disease
- clinical trial
- newly diagnosed
- chronic kidney disease
- ejection fraction
- randomized controlled trial
- squamous cell carcinoma
- physical activity
- depressive symptoms
- risk factors
- spinal cord
- mass spectrometry
- radiation therapy
- social support
- phase ii
- robot assisted
- patient reported outcomes